drugset / Trial / NCT05242783

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:

NCT05242783

Completed 99 enrolled Wael Elbanna Clinic
RandomizedParallel-groupTriple-blindTreatment

Summary

the study aims to evaluate the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level in women undergoing abdominal myomectomy. Moreover, to evaluate their efficacy in decreasing blood loss on operative time and to describe the injection sequelae for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.

Timeline

Start
2022-02-01
Primary completion
2024-03-29
Completion
2024-06-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide Other
Comparator Terlipressin Peptide Other

Indications